Beijing Hotgen Biotech Co.,Ltd (688068.SH) released its semi-annual report for 2024, and the company achieved revenue of 2.49 billion yuan during the reporting period...
Beijing Hotgen Biotech Co.,Ltd (688068.SH) disclosed its semi-annual report for 2024, and the company achieved revenue of 0.249 billion yuan, a year-on-year decrease of 18.96%; net income attributable to the parent company was a loss of 43.47 million yuan, a year-on-year change from profit to loss; non-recurring net income was a loss of 76.83 million yuan, a year-on-year change from profit to loss; basic earnings per share was -0.47 yuan.
